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ABSTRACT: The haplotype harboring the SPINK1 c.101A>G (p.Asn34Ser) variant (also 
known as rs17107315:T>C) represents the most important heritable risk factor for idiopathic 
chronic pancreatitis identified to date. The causal variant contained within this risk haplotype 
has however remained stubbornly elusive. Herein we set out to resolve this enigma by 
employing a hypothesis-driven approach. Firstly, we searched for variants in strong linkage 
disequilibrium with rs17107315:T>C using HaploReg v4.1. Secondly, we identified two 
candidate SNPs by visual inspection of sequences spanning all 25 SNPs found to be in 
linkage disequilibrium with rs17107315:T>C, guided by prior knowledge of pancreas-specific 
transcription factors and their cognate binding sites. Thirdly, employing a novel cis-regulatory 
module-guided approach to further filter the two candidate SNPs yielded a solitary candidate 
causal variant. Finally, combining data from phylogenetic conservation and chromatin 
accessibility, co-transfection transactivation experiments and population genetic studies, we 
suggest that rs142703147:C>A, which disrupts a PTF1L binding site within an evolutionarily 
conserved HNF1A−PTF1L cis-regulatory module located ~4 kb upstream of the SPINK1 
promoter, contributes to the aforementioned chronic pancreatitis risk haplotype. Further 
studies are required not only to improve the characterization of this functional SNP but also to 
identify other functional components that might contribute to this high-risk haplotype. 
 
KEYWORDS: chronic pancreatitis; enhancer; promoter reporter gene assay; regulatory 
variants; SPINK1 gene 
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Introduction  
Chronic pancreatitis is an inflammatory disease of the pancreas that leads to irreversible 
structural and functional damage to the pancreas [Majumder and Chari 2016]. Analysis of 
four genes highly expressed in the pancreatic acinar cells  ̶  PRSS1 (encoding cationic 
trypsinogen; MIM# 276000), PRSS2 (encoding anionic trypsinogen; MIM# 601564), SPINK1 
(encoding pancreatic secretory trypsin inhibitor; MIM# 167790) and CTRC (encoding 
chymotrypsin C (MIM# 601405), which specifically degrades all human trypsinogen/trypsin 
isoforms [Szmola and Sahin-Tóth 2007])  ̶  has defined a trypsin-dependent pathway in the 
pathogenesis of chronic pancreatitis. Whereas gain-of-function missense and copy number 
variants in PRSS1 [Le Maréchal et al., 2006; Whitcomb et al., 1996] and loss-of-function 
variants in SPINK1 [Witt et al., 2000] and CTRC [Masson et al., 2008; Rosendahl et al., 2008] 
predispose to chronic pancreatitis, loss-of-function variants in PRSS1 [Boulling et al., 2015; 
Chen et al., 2003; Derikx et al., 2015; Whitcomb et al., 2012] and PRSS2 [Witt et al., 2006] 
protect against the disease. 
The SPINK1 c.101A>G variant-associated haplotype [Witt et al. 2000] has emerged as the 
most important risk factor for idiopathic chronic pancreatitis as a consequence of its relatively 
high prevalence worldwide (allele frequency,  ̴ 0.7%) and its considerable effect size (odds 
ratio (OR) ≈ 14) [Aoun et al., 2008]. The SPINK1 c.101A>G variant, which was predicted to 
result in a p.Asn34Ser missense mutation, is termed rs17107315:T>C in the dbSNP database 
(https://www.ncbi.nlm.nih.gov/projects/SNP/). For ease of reading, we shall describe this 
variant as rs17107315:T>C (c.101A>G) throughout the manuscript. The identification of the 
causal variant underlying this high-risk haplotype is of considerable biological interest but it 
may also have significant diagnostic and therapeutic value. This notwithstanding, despite 
extensive studies, the underlying causal variant has remained stubbornly elusive [Chen and 
Férec 2009]. The earliest hypothesis, that p.Asn34Ser itself impairs the inhibitory action of 
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SPINK1 on prematurely activated trypsin within the pancreas [Witt et al. 2000], was not 
however supported by biochemical characterization of the wild-type and mutant enzymes 
expressed in three different systems, Saccharomyces cerevisiae BJ1991 strain [Kuwata et al., 
2002], Chinese hamster ovary cells [Boulling et al., 2007], and human embryonic kidney 
293T (HEK293T) cells [Király et al., 2007]. A later hypothesis, that either rs17107315:T>C 
(c.101A>G) or one of the four intronic variants in linkage disequilibrium (LD) with it might 
affect pre-mRNA splicing [Chen et al., 2001], also failed to garner any evidential support 
whether from reverse transcription-PCR (RT-PCR) analysis of total RNA prepared from 
pancreatic tissues of rs17107315:T>C (c.101A>G) homozygotes [Masamune et al., 2007], or 
from experiments performed in the context of both mini-gene [Kereszturi et al., 2009] and 
full-gene [Boulling et al., 2012] systems. An alternative hypothesis, that the causal variant 
resides within an uncharacterized flanking region of the SPINK1 gene with regulatory 
potential [Kereszturi et al. 2009], was explored in the present study.  
 
Material and Methods 
Study Subjects 
The 548 French ICP patients and 562 controls have been previously reported [Fjeld et al., 
2015; Witt et al., 2013]. Most of the 1104 Han Chinese ICP patients and 1196 healthy 
controls have been described in a recent publication [Zou et al., 2016]. The Indian chronic 
pancreatitis patients (n = 347) and controls (n = 264) included in this study have been 
described previously [Paliwal et al., 2013]. Informed consent was obtained from each patient 
and the study was approved by the respective ethics committees of Brest University, the 
Changhai Hospital and the Center for Cellular and Molecular Biology (CSIR-CCMB) in 
Hyderabad.  
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Reference Sequences 
The SPINK1 genomic sequence was obtained from human GRCh37/hg19 
(https://genome.ucsc.edu/). GenBank accession number NM_003122.4 was used as the 
SPINK1 cDNA reference sequence. 
 
Search for Variants in Strong LD with rs17107315:T>C (c.101A>G) Variant 
The search for variants in strong LD with rs17107315:T>C (c.101A>G) variant was 
performed with HaploReg v4.1 
(http://www.broadinstitute.org/mammals/haploreg/haploreg.php) [Ward and Kellis 2016], 
using an LD threshold of r² ≥ 0.40 and querying the 1000 Genomes Project (1000GP) Phase 1 
data (http://www.1000genomes.org/category/phase-1/) in the context of the European 
population. 
 
Verification and Search for HNF1A Binding Sites 
The search for HNF1A binding sites was performed using RSAT (http://www.rsat.eu/) 
[Medina-Rivera et al., 2015] under default conditions, with Homo sapiens GRCh37/hg19 
being used as the organism-specific background. 
 
HNF1A−PTF1L Cis-Regulatory Module (CRM) Prediction 
We performed a comprehensive review of the literature and collated 10 experimentally 
validated PTF1L binding sites within the promoters of human, rat or mouse genes that are 
known to be highly expressed in the pancreatic acinar cells [Beres et al., 2006; Boulling et al., 
2011; Holmstrom et al., 2011]. Each of these PTF1L binding sites comprised a 5' E-Box 
(length = 6) and a 3' TC-Box (length = 7), separated by a 4- or 5-nucleotide spacer sequence 
[Beres et al. 2006; Boulling et al. 2011]. We first aligned the 10 E-Box and 10 TC-Box 
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sequences separately to create two distinct position frequency matrices (PFMs) by counting 
the occurrences of each nucleotide at each position. Then, to construct appropriate PFMs for 
the PTF1L binding site, we separated the E-Box and TC-Box PFMs by 4 or 5 non-specific 
nucleotides to create two PTF1L PFMs, termed PTF1_4N and PTF1_5N, respectively. The 
nucleotide frequency within the spacer was adjusted to correspond to nucleotide frequencies 
in the human genome at large (A: 0.255, T: 0.267, G: 0.242, C: 0.236). Sequence logos for the 
two PTF1L PFMs were created with WebLogo (http://weblogo.berkeley.edu/) [Crooks et al., 
2004]. 
The above generated PTF1L PFMs and the HNF1A (MA0046.2) PFMs provided by the 
JASPAR database (http://jaspar.genereg.net/) [Mathelier et al., 2016] were then used to 
calculate their respective position weight matrices (PWMs). This task was achieved with the 
freely online available RSAT - matrix-scan (full options) tool [Medina-Rivera et al. 2015]. 
PWMs were generated using default parameters with the exception of the “background model 
estimation method” that was set to “organism-specific: Homo sapiens GRCh37”. 
Transcription factor binding site (TFBS) prediction was performed using the “Individual 
Matches” mode with default scanning options. “P-value upper threshold” was exceptionally 
increased to 10-3 to calculate the matrix score for TFBS of weak relevance (i.e., mutated 
TFBSs). The SPINK1 locus plus  20 kb flanking sequences were analyzed for CRM 
prediction using the RSAT CRER scanning option under default conditions, except for the 
following parameters: Lower CRER size = 1, Upper CRER size = 200, site P-value <10-4. 
 
Assessment of Phylogenetic Conservation, Chromatin Accessibility and Histone Marks 
in the Chromosomal Region of Interest 
Phylogenetic conservation data as represented by “Placental Mammal Conservation by 
PhastCons” and “Placental Mammal Conserved Elements” tracks (both using 46 mammal 
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species) were directly taken from the UCSC Genome Browser (https://genome.ucsc.edu/) 
[Kent et al., 2002]. Accessible chromatin regions and histone marks in the pancreatic tissues 
of two donors were obtained from the website of the NIH Roadmap Epigenomics Mapping 
Consortium (http://www.roadmapepigenomics.org/) [Bernstein et al., 2010].  
 
Search for SNPs affecting the Expression of SPINK1 in the Pancreas Tissue 
This analysis was performed using the GTEx dataset available at 
http://www.gtexportal.org/home/) [Carithers et al., 2015]. 
 
Construction of Luciferase Promoter Reporter Plasmids 
A fragment spanning -346 to +49 relative to the transcription start site (i.e., c.1-61 in 
accordance with Yasuda et al. [Yasuda et al., 1998] with the A of the translational initiation 
codon ATG of the gene being designated as c.1) of the SPINK1 gene was first PCR amplified 
from a genomic DNA sample. PCR amplification was performed by means of the HotStarTaq 
Master Mix Kit (Qiagen) with primers (Supp. Table S1) designed to be used with the In-
Fusion® HD Cloning Kit (Clontech, Saint-Germain-en-Laye, France), as previously 
described [Boulling et al., 2015]. The resulting pGL3 reporter construct harboring the wild-
type sequence of the human SPINK1 proximal promoter upstream of the firefly luciferase 
gene was termed hSPINK1pp. The same strategy was used to insert a 330 bp DNA fragment 
containing HNF1A−PTF1L CRM5 into hSPINK1pp at a position downstream of the 
luciferase gene. This was achieved using the primers described in Supp. Table S1, after 
plasmid digestion with BamHI. This latter construct was termed hSPINK1pp+E. All SPINK1 
promoter and enhancer variants were then generated from their respective wild-type 
constructs by site-directed mutagenesis using the Quick Change Site Directed Mutagenesis 
Kit (Stratagene, Massy, France). All resulting plasmids were checked by Sanger sequencing. 
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Construction of Transcription Factor Expression Plasmids 
Human pancreas cDNAs were obtained from 1 µg human pancreas total RNA (Amsbio) by 
reverse transcription using the SuperScript II Reverse Transcriptase (Life Technologies) and 
20mer-oligo(dT) primer (Eurogentec, Angers, France). The obtained cDNAs were treated 
with 2 U RNAse H (Life Technologies) at 37°C for 20 min before being used for PCR 
amplification of the coding sequences of the human RBPJL and HNF1A genes, respectively. 
In parallel, the human PTF1A cDNA clone (OriGene, Rockville, MD) was used to amplify the 
coding sequence of the human PTF1A gene. PCRs were carried out by using the KAPA HiFi 
DNA Polymerase (Kapa Biosystems, Wilmington, MA) with the respective primers described 
in Supp. Table S1. Specifically, 30 (for PTF1A) or 33 (for both RBPJL and HNF1A) cycles of 
amplification were performed, employing an annealing temperature of 65°C. The three 
resulting PCR fragments were purified on an 1.5% agarose gel and cloned into the 
pcDNA™3.1/V5-His-TOPO® (Life Technologies) vector after addition of 3’ A-overhangs by 
Taq DNA Polymerase (Qiagen). The expression constructs thus obtained, which carried the 
coding sequences of the human PTF1A, RBPJL and HNF1A genes, were termed pcDNA3.1-
PTF1A, pcDNA3.1-RBPJL and pcDNA3.1-HNF1A, respectively. The orientation and 
sequence of each insert were checked by sequencing. Plasmids were produced using the 
Nucleobond Xtra Midi EF Kit (Macherey-Nagel). 
 
Cell Culture, Quantitative RT-PCR Analyses, Co-Transfection Transactivation 
Experiments, Luciferase Reporter Gene Assay, and Electrophoretic Mobility Shift 
Assay (EMSA) 
These procedures are described in Supp. Methods. 
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Analysis of rs142703147:C>A and rs17107315:T>C (c.101A>G) in French, Chinese and 
Indian Subjects 
The procedures for sequencing the two polymorphic sites are described in Supp. Methods. 
The LD between the two SNPs was calculated by means of CubeX 
(http://www.oege.org/software/cubex/) [Gaunt et al., 2007]. To test for the effect of one SNP 
being conditional upon the other, a logistic regression model was used where the log(oddsi) of 
disease of each individual i was modeled as a linear function of the minor allele dosage gi,k at 
each SNP k (gi,k =0, 1 or 2) and the additive effect of this minor allele ßk. An indicator 
variable i was added to the model to account for the geographic origin of the individuals. The 
full model (1) with the effects of the two SNPs was compared against each restricted model 
with respectively ß1 and ß2 set to zero to test for the effect of each SNP conditional upon the 
other:    iiii ggodds   2,21,1log   (1) 
The significance of the improvement in fit was tested by comparing the difference of 
deviances to a distribution with 1 degree of freedom. The glm() function of R version 3.2.2 
was used for fitting the model [R Core Team, 2015]. 
 
Results 
Search for Variants in Perfect or Strong LD with rs17107315:T>C (c.101A>G) 
A causal variant residing within an uncharacterized flanking region of the SPINK1 gene has 
been hypothesized to underlie the SPINK1 c.101A>G variant-associated haplotype 
[Kereszturi et al. 2009]. Such a variant should in principle be in perfect (or at least very 
strong) LD with the SPINK1 c.101A>G variant and would be predicted to impact the binding 
site for a functionally relevant transcription factor. We tested this postulate by means of 
HaploReg v4.1 [Ward and Kellis 2016], using an LD threshold of r² ≥ 0.40 and querying the 
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1000GP Phase 1 data in the context of the European population. We identified a total of 25 
SNPs in LD with rs17107315:T>C (c.101A>G), whose r² values ranged from 0.87 to 1; all 
but one of these SNPs were located within the region spanning 20 kb 3' of SPINK1 to 18 kb 5' 
of SPINK1 (Supp. Fig. S1). Of the HaploReg v4.1-annotated motifs that were altered by these 
SNPs, only the HNF1A motif, impacted by rs17107287:C>T (Supp. Fig. S1), was deemed to 
be of potential functional interest owing to the known role of HNF1A in pancreatic exocrine 
physiology [Boulling et al. 2011; Molero et al., 2012]. However, we were unable to validate 
this prediction using RSAT under default conditions [Medina-Rivera et al. 2015]. 
 
Identification of Two SNPs that Potentially Disrupt a PTF1L Binding Site by Visual 
Inspection 
Assuming that the hypothesis that the causal variant resides within a flanking region of the 
SPINK1 gene [Kereszturi et al. 2009] was nevertheless correct, and that we had successfully 
identified all the SNPs in strong or perfect LD with rs17107315:T>C (c.101A>G) variant, the 
most probable reason for failing to confirm our prediction was deemed to be that a 
functionally relevant transcription factor binding site (TFBS) had been missed by the relevant 
search programs. We previously encountered just such a case during the functional 
characterization of SPINK1 promoter variants; an HNF1A binding site was readily predicted 
by MATCH (http://www.gene-regulation.com/pub/programs.html#match) but a PTF1L 
binding site was identified instead by visual inspection [Boulling et al. 2011] (Fig. 1A). 
PTF1L is a pancreatic-specific trimeric complex comprising PTF1A, RBPJL and one of the 
several ubiquitously expressed class A bHLH family members [Boulling et al. 2011; 
Holmstrom et al. 2011; Masui et al., 2008]. We therefore visually inspected the local DNA 
sequence spanning all the aforementioned 25 SNPs (Supp. Fig. S1) against the previously 
described canonical sequence of PTF1L TFBS, CACCTG….TTTCCC [Boulling et al. 2011]. 
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We identified two SNPs, rs142703147:C>A (Fig. 1B) and rs192858015:G>A, to disrupt a 
putative PTF1L TFBS.  
 
Using a Putative HNF1A−PTF1L CRM to Filter rs142703147:C>A and 
rs192858015:G>A 
There is increasing evidence that the spatial and temporal expression of genes is enabled by 
the coordinated action of multiple transcription factors through CRMs [Lelli et al., 2012]. 
Moreover, distal CRMs, also called enhancers, can often be predicted by sequence signatures 
extracted from proximal promoters [Taher et al., 2013]. Given the important roles played by 
HNF1A and PTF1L in adult pancreatic acinar cells [Holmstrom et al. 2011; Masui et al. 2008; 
Molero et al. 2012], it did not appear unreasonable to speculate that their closely spaced 
TFBSs within the SPINK1 proximal promoter (Fig. 1A) could define such a CRM. We 
therefore screened the 200 bp sequences flanking rs142703147:C>A and rs192858015:G>A 
by means of RSAT [Medina-Rivera et al. 2015] and identified a putative HNF1A TFBS only 
in the immediate vicinity of rs142703147:C>A (Fig. 1B). In other words, of the two SNPs, 
only rs142703147:C>A occurred within a putative HNF1A−PTF1L CRM. rs142703147:C>A 
corresponds to c.1-4141G>T in accordance with the A of the translational initiation codon 
ATG of the SPINK1 gene being designated as c.1 [den Dunnen et al., 2016]. This variant will 
be described as rs142703147:C>A (c.1-4141G>T) in the following sections. 
 
In Silico Evidence Supporting the Functional Relevance of the rs142703147:C>A (c.1-
4141G>T)-Affected HNF1A−PTF1L CRM in Vivo 
To provide supporting evidence that the rs142703147:C>A (c.1-4141G>T)-affected 
HNF1A−PTF1L CRM is of functional relevance in vivo, we sought to compare it with other 
nearby “HNF1A−PTF1L” CRMs in terms of both evolutionary conservation, chromatin 
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accessibility and histone marks [Shlyueva et al., 2014]. To this end, we first built PFMs for 
the bipartite PTF1L motif, with the E-Box and TC-Box being separated respectively by 4 bp 
and 5 bp (Fig. 2A,B). We then converted the PTF1L PFMs and JASPAR-derived HNF1A 
PFMs to their respective PWMs and scanned the SPINK1 locus plus 20 kb flanking regions 
for putative HNF1A−PTF1L CRMs by means of RSAT [Medina-Rivera et al. 2015]. In 
addition to the HNF1A−PTF1L CRM illustrated in Fig. 1A (termed CRM4) and that 
illustrated in Fig. 1B (termed CRM5), four additional putative CRMs were identified (i.e., 
CRMs 1, 2, 3 and 6; Fig. 1C). It is pertinent to mention that two putative PTF1L binding sites 
were also predicted immediately upstream of the HNF1A binding site in the proximal 
promoter (see Fig. 1A). However, these PTF1L binding sites were excluded from further 
consideration because neither of them was located within an evolutionarily conserved region.  
Of the 6 CRMs, only CRM4 and the rs142703147:C>A (c.1-4141G>T)-affected CRM5 
were found to be located within the most evolutionarily conserved regions. Further, each of 
the top three chromatin accessible regions obtained from human pancreatic tissue contains a 
HNF1A−PTF1L CRM (CRMs 4-6) (Fig. 1C), indicating their likely functional importance in 
vivo. Here it is important to emphasize that, with the exception of rs142703147:C>A (c.1-
4141G>T), all the other SNPs in LD with rs17107315:T>C (c.101A>G) were not found 
within a HNF1A−PTF1L CRM, and fell outside of the most accessible chromatin and the 
most evolutionarily conserved regions (Fig. 1C).  
Using data from the website of the NIH Roadmap Epigenomics Mapping Consortium, we 
did not find any strong histone 3 lysine 4 monomethylation (H3K4me1) or H3K27 acetylation 
(H3K27ac) marks across the SPINK1 locus plus 20 kb flanking regions in the human 
pancreatic tissues of two healthy donors (Supp. Fig. S2). In addition, no SNPs were found to 
affect the expression of SPINK1 in human pancreas in the GTEx database. 
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Co-Transfection Transactivation Experiments Demonstrating Functional Synergy 
between the HNF1A and PTF1L Transcription Factors in Regulating the Promoter 
Activity of the SPINK1 Gene 
The premise of the CRM concept is that multiple transcription factors cooperate in regulating 
gene expression through concomitant binding to their cognate binding sites in a gene’s 
regulatory sequence. We therefore tested the functional synergy between the HNF1A and 
PTF1-L transcription factors in regulating the promoter activity of the SPINK1 gene by means 
of a co-transfection transactivation assay, which was performed essentially as previously 
described [Holmstrom et al. 2011]. To this end, we constructed a promoter-reporter vector 
wherein a CRM4-containing SPINK1 promoter sequence was cloned into the pGL3 basic 
vector upstream of the firefly luciferase gene (termed hSPINK1pp) and three pcDNA3.1 
expression vectors containing the coding sequences of the PTF1A, RBPJL and HNF1A genes, 
respectively. The co-transfection transactivation assay had to be performed in a cell line that 
lacked endogenous expression of these transcription factors; the non-pancreatic HEK293T 
cell line, which was confirmed to lack expression of the three transcription factor genes as 
well as the SPINK1 gene by quantitative RT-PCR analysis (Supp. Fig. S3A), was used for this 
purpose. A further stipulation was that none of the co-transfected transcription factors should 
induce spurious expression of the luciferase reporter gene through binding to non-specific 
sequences within the vector. We verified this by co-transfecting the promoter-lacking pGL3-
basic vector with the different transcription factor expression plasmids, either individually or 
in combination, and found no significant increase of the luciferase reporter gene under any 
conditions (Supp. Fig. S3B).  
Having validated the experimental system, we first co-transfected the hSPINK1pp vector 
with the expression vectors containing the three transcription factors. It should be appreciated 
that the function of the PTF1L transcription factor is executed by a combination of PTF1A, 
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RBPJL and one of the several ubiquitously expressed class A bHLH family members 
[Boulling et al. 2011; Holmstrom et al. 2011; Masui et al. 2008]. SPINK1 promoter reporter 
gene activity increased 1.8-fold and 1.3-fold upon expression of HNF1A alone and PTF1A + 
RBPJL alone, respectively, but increased 6.3-fold upon expression of all three (Fig. 3). These 
observations were interpreted in terms of a synergistic effect between the HNF1A and PTF1-
L transcription factors.  
Two variants residing within the CRM4 HNF1A binding site in the SPINK1 promoter 
have been reported to predispose to chronic pancreatitis (Fig. 1A). Both variants were 
predicted to disrupt the HNF1A binding site (Fig. 4A). We tested their potential effects on the 
cooperative action between the HNF1A and PTF1L transcription factors and found that each 
resulted in the abolition of the aforementioned synergistic effect (Fig. 4B).  
These two complementary lines of evidence, taken together, underscore the importance for 
SPINK1 gene regulation of the coordinated action of HNF1A and PTF1L through binding to 
their cognate binding sites within the context of a functional CRM. 
 
Co-Transfection Transactivation Assay Testing the Functional Effect of the 
rs142703147C>A (c.1-4141G>T)-Variant on Regulating the Promoter Activity of the 
SPINK1 Gene 
The rs142703147:C>A (c.1-4141G>T)-variant was predicted to have a lower PWM score 
than the wild-type rs142703147C allele (Fig. 5A), suggestive of reduced affinity for the 
PTF1L transcription factor. The current ‘gold standard’ in vitro method to evaluate the effect 
of an enhancer element is to place it in the vicinity of a promoter element in a reporter gene 
assay [Shlyueva et al. 2014]. We therefore inserted a fragment containing the HNF1A−PTF1L 
CRM5 into hSPINK1pp at a position downstream of the luciferase gene; the resulting 
hSPINK1pp+E [C] vector was then used to introduce the rs142703147A variant. The 
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hSPINK1pp+E [C] vector and the corresponding rs142703147A vector, hSPINK1pp+E [A], 
were co-transfected respectively with the three transcription factor expression plasmids. The 
major C allele, but not the minor A allele, of rs142703147 significantly enhanced reporter 
gene expression induced by the three co-transfected transcription factors in HEK293 cells 
(Fig. 5B). This demonstrated that rs142703147C>A (c.1-4141G>T) is a loss-of-function 
variant, consistent with the known role of the SPINK1 gene in the etiology of chronic 
pancreatitis.  
We also performed this analysis in rat pancreatic acinar AR42J cells treated with 
dexamethasone. Under our experimental conditions, hSPINK1pp drove a mere 2.3-fold 
increased expression of the reporter gene as compared with the promoterless pGL3 basic 
vector and no significant difference was observed between the two alleles of rs142703147 in 
enhancing hSPINK1pp-driven reporter gene expression (Supp. Fig. S4A). Analysis of the 
relative mRNA expression levels of the rat Prss1, Ctrc, Spink1, Ptf1a, Rbpj1, Hnf1a genes in 
the dexamethasone-differentiated AR42J cells indicated poor expression of both the Spink1 
and Hnf1a genes (Supp. Fig. S4B). 
 
EMSA Providing Further Supporting Evidence for the Functional Effect of the 
rs142703147C>A (c.1-4141G>T) Variant 
We further performed EMSA using nuclear extracts prepared from HEK293T cells 
transfected with the two expression plasmids encoding respectively the PTF1A and RBPJL 
genes. This assay demonstrated that rs142703147A disrupted the interaction between the 
PTF1L transcription factor and its cognate binding site (Fig. 6). 
 
Additional Data from Population Genetic Analyses 
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Analysis of 548 French ICP patients and 562 ethnogeographically-matched controls (Supp. 
Table S2) showed that rs142703147:C>A (c.1-4141G>T) is in perfect LD with the 
rs17107315:T>C (c.101A>G) variant in this population (r² = 1). However, analysis of the two 
SNPs in 1104 Chinese ICP patients and 1196 controls as well as in 347 Indian patients and 
264 controls (Supp. Table S2) showed that they are not in perfect LD in these two populations 
(Chinese, r² = 0.80; Indian, r² = 0.59). Similar OR values were obtained between the 
rs142703147:A (c.1-4141T) allele and the rs17107315:C (c.101G) allele: 6.13 versus 5.47 in 
the Chinese dataset (Supp. Table S3) and 15.12 versus 14.82 in the Indian dataset (Supp. 
Table S4).  
  To test whether the two SNPs had an impact on disease risk, conditional analyses were 
performed. Nested logistic regression models were fitted viz. M1, effect of SNP1 
(rs142703147:C>A) + ethnicity; M2, effect of SNP2 (rs17107315:T>C) + ethnicity; and M3 
(i.e., the full model), effect of SNP1 + effect of SNP2 + ethnicity. By comparing the 
likelihood of M2 versus M3, we tested for the effect of SNP1 conditional upon SNP2, 
obtaining a χ2 value of 5.65 and a P value of 1.74 × 10-2. By comparing the likelihood of M1 
versus M3, we tested for the effect of SNP2 conditional upon SNP1, obtaining a χ2 value of 
30.65 and a P value of 3.09 × 10-8. These results suggested that both SNPs exert an effect on 
disease risk.  
 
Discussion 
The association of the rs17107315:T>C (c.101A>G)-containing haplotype with chronic 
pancreatitis was first described 16 years ago [Witt et al. 2000]. As opined by Kereszturi and 
colleagues, “The mechanism of action of the [SPINK1] p.Asn34Ser-associated haplotype 
remains one of the most intriguing, unsolved questions of pancreas genetics” [Kereszturi et al. 
2009]. These authors proposed that the causal variant was most probably located within an 
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uncharacterized flanking region of the SPINK1 gene. However, distal regulatory variants are 
notoriously difficult to identify because the causal variant-harboring regulatory elements act 
independently of the distance and orientation to their target genes [Mathelier et al., 2015; 
Shlyueva et al. 2014]. Herein we have related a somewhat unusual and rather atypical story 
about how a functional regulatory variant was finally identified after a 16 year interlude. We 
started out by adopting a hypothesis-driven approach to identify all variants in strong or 
perfect LD with the rs17107315:T>C (c.101A>G) variant. Somewhat surprisingly, none of 
the LD SNPs were predicted to affect a functionally relevant TFBS. However, we identified 
two candidate SNPs that affected potential PTF1L binding sites by visual inspection of DNA 
sequence spanning all 25 LD SNPs, guided by prior knowledge of pancreas-specific 
transcription factors and their cognate binding sites. With hindsight, the failure to identify 
potential PTF1-L binding sites by all currently available TFBS prediction programs was 
almost certainly due to the variable length of the spacer sequence that separates the E-Box and 
TC-Box of the bipartite PTF1-L binding site (see Fig. 2).  
 Employing a novel CRM-based approach to filter the aforementioned two SNPs, we 
excluded one of them from further consideration. The remaining single variant, 
rs142703147C>A (c.1-4141T), is located approximately 4-kb from the SPINK1 promoter, 
consistent with the current consensus that enhancers tend to be located within 10 kb of their 
associated transcription start sites genome-wide [MacIsaac et al., 2010; Taher et al. 2013]. 
The functionality of this variant was strongly supported by evolutionary conservation and 
chromatin accessibility data (Fig. 1C). By contrast, based upon ChIP-seq data from the human 
pancreatic tissues of two donors, no strong enhancer-associated histone marks (i.e., H3K4me1 
and H3K27ac) were noted in the vicinity of the rs142703147C>A (c.1-4141T)-affected motif 
(Supp. Fig. S2). However, it is known that (i) none of the known histone modifications 
correlate perfectly with enhancer activity and (ii) there is no evidence that either H3K4me1 or 
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H3K27ac is sufficient, necessary or even mechanistically involved in transcription [Shlyueva 
et al., 2014]. Additionally, in the publicly available GTEx dataset, no single SNP is known to 
influence SPINK1 expression in the pancreas. As far as rs142703147C>A (c.1-4141T) is 
concerned, this variant might simply not have been included for analysis by GTEx due to its 
low allele frequency in normal populations.  
The functionality of the rs142703147C>A (c.1-4141T) variant was further supported by a 
series of experiments performed in HEK293T cells (Figs. 3-6). In this regard, it should be 
emphasized that there are no human pancreatic cell lines currently available for performing 
SPINK1 promoter or enhancer reporter gene assays on a physiologically relevant background. 
The co-transfection transactivation assay used here, performed in cells lacking endogenous 
expression of the relevant transcription factors [Holmstrom et al. 2011], overcame this 
technical limitation. This notwithstanding, one may surmise that dexamethasone-
differentiated rat pancreatic acinar AR42J cells [Rajasekaran et al., 1993], which have been 
previously used for analyzing PRSS1 [Boulling et al., 2015] and SPINK1 [Derikx et al., 2015] 
promoter variants, may be relevant with respect to the current ‘gold standard’ in vitro method 
for evaluating the effect of an enhancer element placed in the vicinity of a promoter element 
in a reporter gene assay [Shlyueva et al. 2014]. We therefore performed this analysis in 
AR42J cells treated with dexamethasone but did not obtain expected results (Supp. Fig. S4A). 
This can be essentially accounted for by the poor expression of both the Spink1 and Hnf1a 
genes in the AR42J cells treated with dexamethasone (Supp. Fig. S4A). Here it is pertinent to 
note that in the current study, the inserted SPINK1 promoter drove a mere 2.3-fold increased 
expression of the reporter gene as compared with the promoterless pGL3 basic vector (Supp. 
Fig. S4B) whilst in a previous reporter gene assay, the corresponding increase for the inserted 
SPINK1 promoter was >15-fold [Derikx et al., 2015]. A variety of parameters affecting cell 
characteristics that pertain to cell culture conditions, including medium used, fetal bovine 
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serum percentage and composition, cell confluence, number of cell passages at time of 
transfection and protocol for dexamethasone treatment, could have significantly affected the 
experimental outcomes [Baker et al., 2016]. Additionally, the SPINK1 promoter sequence 
used for reporter gene assay differs between the current study and the previous study [Derikx 
et al., 2015]; the inserted promoter segments correspond to c.1-407 to c.1-13 and c.1-541 to 
c.35 of the SPINK1 genomic sequence, respectively. Finally, we should add that we did not 
attempt to perform experiments in mouse-derived pancreatic acinar tumor 266-6 cells because 
these cells displayed no difference with HEK293T cells in terms of SPINK1 promoter-driven 
reporter gene expression [Derikx et al., 2015]. 
Although we provide strong in silico and in vitro evidence that the rs142703147C>A 
(c.1-4141T) variant is of functional significance, our findings from population genetic studies 
clearly suggest that it is only one component of the chronic pancreatitis-predisposing 
functional elements contained within the risk haplotype of interest. Thus, we are still far from 
obtaining a complete understanding of the pathogenic mechanism(s) underlying the most 
important heritable risk factor for idiopathic chronic pancreatitis identified to date [Witt et al. 
2000] even after a 17 year interlude. Indeed, even though a cis variant located in the 
immediate vicinity of the gene under study would be a priority in terms of being tested, the 
true causative variant can be located at some distance from the haplotype associated with the 
phenotype (Smemo et al., 2014). Further studies that aim to discover other variants 
contributing to the high-risk haplotype as well as to improve the characterization of the 
functional SNP identified here are warranted. In a more general context, our case serves to 
exemplify the difficulties that are frequently encountered in tracking down and unmasking the 
causal variants responsible for disease associations that reside within the extensive regulatory 
regions flanking our genes rather than within the gene coding regions themselves [Mathelier 
et al. 2015; Spielmann and Mundlos 2016; Yao et al., 2015]. Nonetheless, the novel approach 
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employed in this study will, we believe, help to stimulate the development of new strategies to 
identify the causal regulatory variants underlying many human inherited disease associations. 
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Figure legends 
Figure 1.   Discovery of a candidate causal variant underlying the chronic pancreatitis-
associated SPINK1 c.101A>G (rs17107315:T>C) variant-containing haplotype. A: The 
HNF1A and PTF1-L binding sites previously identified within the SPINK1 proximal 
promoter [Boulling et al. 2011]. This motif signature corresponds to CRM4 illustrated in C. 
Note that (i) the nucleotide positions are in accordance with the A of the translational 
initiation codon ATG of the SPINK1 gene being designated as c.1; (ii) the sequence given is 
on the sense strand with respect to the reading frame of the SPINK1 gene; (iii) HNF1A and 
PTF1L were previously termed HNF1 and PTF1, respectively [Boulling et al. 2011]; and (iv) 
the TC-Box of the PTF1L binding site was previously annotated as comprising 6 nucleotides 
[Boulling et al. 2011]. Two chronic pancreatitis-predisposing variants that occurred within the 
HNF1A binding site, c.147A>G and c.142T>C [Boulling et al. 2011], are also shown. B: 
Illustration of the bipartite PTF1L TFBS disrupted by rs142703147C>A (c.1-4141G>T) and 
the RSAT-predicted HNF1A TFBS. This panel represents an enlarged view of CRM5 
illustrated in C. Nucleotide positions are in accordance with hg19, with the A of the 
translational initiation codon ATG of the SPINK1 gene being designated as c.1. It should be 
noted that the sequence is given on the antisense strand with respect to the reading frame of 
the SPINK1 gene. N55 indicates 55 nucleotides whose sequence is not shown. C: Evaluation 
of the predicted putative PTF1L−HNF1A CRMs within the SPINK1 locus plus  20 kb 
flanking sequence in the context of phylogenetic conservation and accessible chromatin 
regions. PC and CE, Placental Mammal Conservation by PhastCons and Placental Mammal 
Conserved Elements obtained from the UCSC Genome Browser. Accessible DNA regions in 
the pancreatic tissues of two donors, as determined by DNase-seq, were obtained from the 
website of the NIH Roadmap Epigenomics Mapping Consortium. LD SNPs refer to all the 
SNPs (with the exception of the below described rs138251740A>G; see Supp. Fig. S1) that 
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were found to be in strong or perfect LD with the rs17107315T>C (c.101A>G) variant 
(highlighted in green). Apart from rs17107315T>C (c.101A>G) and rs142703147C>A (c.1-
4141G>T), the other two SNPs that were specifically mentioned in the manuscript (i.e., 
rs17107287C>T and rs192858015G>A) are also clearly indicated. Note that the not shown 
rs138251740A>G (located further downstream of chr5:147,230,000) is located neither within 
a putative PTF1L−HNF1A CRM nor within a region showing strong evolutionary 
conservation and high chromatin accessibility.  
 
Figure 2.   Construction of two PFMs for the bipartite PTF1L binding site. A: Sequence 
alignment of 10 experimentally validated PTF1L TFBSs. Each of these PTF1L TFBSs 
comprised a 6-bp E-Box motif and a 7-bp TC-Box motif, separated by a 4- or 5- nucleotide 
spacer sequence (4N or 5N). The aligned E-Box and TC-Box sequences were used to generate 
two distinct PFMs. Nucleotides that are not perfectly conserved within the E-Box or TC-Box 
are highlighted in red. Luc., luciferase reporter gene assay. B: Sequence logos for the two sets 
of PTF1L PFMs, PTF1_4N and PTF1_5N. They were generated by inserting a 4- or 5- 
nucleotide spacer sequence between the aforementioned E-Box and the TC-Box PFMs.  
 
Figure 3.   Induction of luciferase reporter gene activity driven by the CRM4-containing 
SPINK1 promoter (hSPINK1pp) upon expression of the co-transfected transcription factors. 
Expression level of the SPINK1 promoter-driven luciferase reporter gene co-transfected with 
the empty pcDNA3.1 (+) vector (Empty) is set to 1. H, HNF1A; P, PTF1A; R, RBPJL. Bars, 
SD. *, P<0.05; **, P<0.01; ***, P<0.001. 
 
Figure 4.   Effects of two chronic pancreatitis-predisposing SPINK1 promoter variants on 
HNF1A- or PTF1L−HNF1A-induced luciferase reporter gene activity. A: Predicted effects of 
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the two chronic pancreatitis-predisposing variants [Boulling et al. 2011] on the HNF1A 
binding site located within CRM4 in the SPINK1 proximal promoter. The PWM scores are 
shown for each of the wild-type (WT) and variant sequences. A P value of <10-4 was regarded 
as being a potential TFBS. *, P < 10-3; ***, P <10-5. B: Co-transfection transactivation 
experiments performed under different conditions. Expression levels of the luciferase reporter 
gene activity driven by the CRM4-containing wild-type, c.142T>C or c.147A>G SPINK1 
promoter co-transfected with the empty pcDNA3.1 (+) vector (Empty) is set to 1. Each of the 
wild-type and variant SPINK1 promoter reporter gene vectors was co-transfected with the 
expression plasmid encoding the HNF1A gene only (HNF1A) and the three expression 
plasmids encoding respectively the PTF1A, RBPJL and HNF1A genes (P+R+H). Bars, SD. 
**, P<0.01; ***, P<0.001. 
 
Figure 5.   Functional effect of the rs142703147C>A (c.1-4141G>T) variant on regulating 
SPINK1 promoter activity by means of a co-transfection transactivation assay. A: Predicted 
effect of the rs142703147C>A (c.1-4141G>T) variant on the PTF1L binding site located 
within CRM5. The PWM scores are shown for the wild-type and variant alleles of 
rs142703147. A P value of <10-4 was regarded as being a potential TFBS. **, P < 10-4; ***, P 
<10-5. B: Effects of the wild-type and variant CRM5 with respect to the rs142703147 
polymorphic site, when inserted separately into hSPINK1pp, on PTF1A+RBPJL+HNF1A 
(P+R+H)-induced reporter gene expression. Expression levels of the reporter gene constructs 
co-transfected with the empty pcDNA3.1 (+) vector are set to 1. hSPINK1pp+E [C], wild-
type CRM5 inserted into the hSPINK1pp vector; hSPINK1pp+E [A], rs142703147A-
containing CRM5 inserted into the hSPINK1pp vector. Bars, SD. ***, P<0.001.  
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Figure 6.   Functional characterization of rs142703147C>A (c.1-4141G>T) by EMSA. Upper 
panel shows the sequence of the biotinylated probe and specific competitor (Comp.) with 
respect to the wild-type C allele of rs142703147 (first line) and the sequence of the variant 
rs142703147A allele competitor (second line). Only the sense strand of the double stranded 
oligonucleotide is shown. Lower panel shows the EMSA results performed with labelled 
probe C incubated with nuclear extracts (NE) from HEK293T cells transfected with empty 
pcDNA3.1 vector (E) or with PTF1A (P) and RBPJL (R) expression plasmids, in the presence 
or absence of Competitor C, Competitor A or Irrelevant (Ir) competitor. Competitors were 
added at a 50- or 100-fold excess compared with the biotinylated probe. The arrow indicates 
the position of the DNA/PTF1L complex. 
 
